No insider purchase over the last 90 days. The latest was filed 08 Jun 2026.
Evonik Industries AG, classified in the Chemicals & Materials sector, is a listed company based in Essen, Germany, founded in 2007. Its latest reported headcount is 31,053 employees (2026). Its insiders report their share dealings to BaFin. In the past year (18 October 2025 to 18 October 2026), 9 filings came from 3 insiders.
Every open-market trade in the period is a purchase: 9 purchases worth €624k, from 3 insiders, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 2 senior executives and 1 board member among the declarants. The largest single trade was a purchase of €100k by Kjeldsen, Lauren, published on 23 April 2026, equal to 0.0012% of the market capitalisation.
In the case of 4 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (8 June 2026) now reads 131 days. Typically, a trade is published a median of 4 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade.
For context, the typical company on the same exchange (median of 287 companies) published 5 filings over the same period, against 9 filings here. The full history, which starts in 2025, counts 14 purchases against no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. This summary is built from BaFin disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Evonik Industries AG Hold (neutral), based on 12 analysts. Average price target: €18.43.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
14 of 14 declarations
Evonik Industries AG is a specialty chemicals group listed on Xetra/Frankfurt (DAX/MDAX/SDAX) in Germany and headquartered in Essen. The company in its current form dates back to September 12, 2007, when RAG-Beteiligungs-AG was renamed Evonik Industries AG. Its industrial roots are far older: Theodor Goldschmidt founded Chemische Fabrik Th. Goldschmidt in Berlin in 1847, and the business later moved to Essen, where it helped establish the Goldschmidtstraße site. Today, Evonik is a global specialty chemicals company with operations in more than 100 countries, production plants in 27 countries, and about 31,000 employees.\n\nEvonik’s business model is centered on higher-value niche positions rather than commodity chemicals. The group states that around 80% of sales come from market-leading positions, which supports pricing power, customer stickiness, and resilience across cycles. Since 2025, the company has reorganized its operating business into two core segments, Custom Solutions and Advanced Technologies, with an additional Infrastructure segment. This structure is intended to better separate customer-facing solution businesses from technology- and efficiency-driven platforms. Key business lines include additives for coatings, adhesives and polyurethane foams, catalysts, specialty amines, ingredients for cosmetics and home care, high-performance polymers, crosslinkers, hydrogen peroxide, animal nutrition amino acids, and solutions for health care and biopharma.\n\nFrom a competitive perspective, Evonik stands out for its broad application expertise, strong R&D culture, and international manufacturing footprint. Its strategic growth themes are precision biosolutions, circular economy, and energy transition, reflecting management’s intent to create additional sales over the medium term from innovation-led platforms. The company’s product portfolio is embedded in end markets such as automotive, construction, plastics, energy, coatings, and life sciences, where performance, formulation know-how, and regulatory compliance are critical.\n\nRecent developments reinforce this positioning. In 2025, Evonik advanced sustainability initiatives by switching selected production lines to renewable electricity, opening a large alkoxides plant in Singapore, and announcing partnerships focused on thermoplastic automation and recycling. In February 2026, the company confirmed that it had met its 2025 guidance and introduced a new dividend policy. For investors, Evonik combines the characteristics of a defensive specialty chemicals platform with global reach, a significant innovation engine, and value-creation potential linked to portfolio simplification and operational efficiency.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Essen, Germany · Founded: 2007 · 31,053 employees (2026) · Wikipedia article
Source: Wikidata (CC0).